243 related articles for article (PubMed ID: 21067840)
1. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.
Calvisi DF; Ladu S; Conner EA; Seo D; Hsieh JT; Factor VM; Thorgeirsson SS
J Hepatol; 2011 Feb; 54(2):311-9. PubMed ID: 21067840
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
3. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
[TBL] [Abstract][Full Text] [Related]
5. The GAPs between hepatocellular carcinoma and RAS.
Guachalla LM; Rudolph KL
J Hepatol; 2011 Feb; 54(2):191-2. PubMed ID: 21093951
[No Abstract] [Full Text] [Related]
6. Reduced expression of RAS protein activator like-1 in gastric cancer.
Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M
Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
[TBL] [Abstract][Full Text] [Related]
8. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
9. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.
Delire B; Stärkel P
Eur J Clin Invest; 2015 Jun; 45(6):609-23. PubMed ID: 25832714
[TBL] [Abstract][Full Text] [Related]
10. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
[TBL] [Abstract][Full Text] [Related]
11. A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.
Kolfschoten IG; van Leeuwen B; Berns K; Mullenders J; Beijersbergen RL; Bernards R; Voorhoeve PM; Agami R
Cell; 2005 Jun; 121(6):849-58. PubMed ID: 15960973
[TBL] [Abstract][Full Text] [Related]
12. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
Calvisi DF; Pinna F; Pellegrino R; Sanna V; Sini M; Daino L; Simile MM; De Miglio MR; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Int J Cancer; 2008 Nov; 123(9):2057-64. PubMed ID: 18697198
[TBL] [Abstract][Full Text] [Related]
13. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
Newell P; Toffanin S; Villanueva A; Chiang DY; Minguez B; Cabellos L; Savic R; Hoshida Y; Lim KH; Melgar-Lesmes P; Yea S; Peix J; Deniz K; Fiel MI; Thung S; Alsinet C; Tovar V; Mazzaferro V; Bruix J; Roayaie S; Schwartz M; Friedman SL; Llovet JM
J Hepatol; 2009 Oct; 51(4):725-33. PubMed ID: 19665249
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
Tai WT; Chen YL; Chu PY; Chen LJ; Hung MH; Shiau CW; Huang JW; Tsai MH; Chen KF
Hepatology; 2016 May; 63(5):1528-43. PubMed ID: 26840794
[TBL] [Abstract][Full Text] [Related]
15. RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway.
Chen H; Cheng ZY; Pan Y; Wang Z; Liu Y; Zhang JQ
Hum Cell; 2014 Jul; 27(3):103-10. PubMed ID: 24531877
[TBL] [Abstract][Full Text] [Related]
16. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS.
Duan YF; Li DF; Liu YH; Mei P; Qin YX; Li LF; Lin QX; Li ZJ
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):204-9. PubMed ID: 23558076
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC
J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345
[TBL] [Abstract][Full Text] [Related]
19. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
Chan LH; Zhou L; Ng KY; Wong TL; Lee TK; Sharma R; Loong JH; Ching YP; Yuan YF; Xie D; Lo CM; Man K; Artegiani B; Clevers H; Yan HH; Leung SY; Richard S; Guan XY; Huen MSY; Ma S
Cell Rep; 2018 Oct; 25(3):690-701.e8. PubMed ID: 30332648
[TBL] [Abstract][Full Text] [Related]
20. An expanding role for RAS GTPase activating proteins (RAS GAPs) in cancer.
Maertens O; Cichowski K
Adv Biol Regul; 2014 May; 55():1-14. PubMed ID: 24814062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]